Glimepiride Tablet
Product Images NDC 72789-048

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Glimepiride (NDC 72789-048). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789048 Label (72789048)

Glimepiride USP 4 mg oral tablet label showing 30 tablets per package. The label includes the NDC 72789-048-30 and is from PD-Rx Pharmaceuticals, Inc., located in Oklahoma City, OK. The label presents drug identification, lot number A20C01, and expiration date 06/2021, along with warnings and dosage instructions.*

FDA Label Image

Figure (Gli00 0001 03)

Glimepiride 4 mg oral tablets in a white tablet form with the imprint '117' on one side and a scored line on the other. The image shows a single tablet, indicating a tablet dosage form for oral administration.*

FDA Label Image

Structural Formula (Gli00 0001 04)

Chemical structure of Glimepiride, showing its molecular framework with distinctive ring and functional group arrangements as depicted in the image.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.